Patents by Inventor Hao Yi Liang

Hao Yi Liang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Materials and methods for treating viral infections
    Patent number: 9283198
    Abstract: The subject invention provides materials and methods for treating various health conditions, including the prevention and/or treatment of a viral infection. In a preferred embodiment, a cysteamine compound is administered to a subject to treat an influenza virus infection. More preferably, a cysteamine compound is administered to a subject to treat influenza A, influenza B, influenza C virus infections, including avian influenza virus subtypes (such as H5N1 avian influenza virus).
    Type: Grant
    Filed: April 4, 2013
    Date of Patent: March 15, 2016
    Assignee: OBIO PHARMACEUTICAL (H.K.) LIMITED
    Inventors: Hao Yi Liang, Francis Chi, Qingfu Xu, Bill Piu Chan
  • MATERIALS AND METHODS FOR TREATING VIRAL INFECTIONS
    Publication number: 20130338113
    Abstract: The subject invention provides materials and methods for treating various health conditions, including the prevention and/or treatment of a viral infection. In a preferred embodiment, a cysteamine compound is administered to a subject to treat an influenza virus infection. More preferably, a cysteamine compound is administered to a subject to treat influenza A, influenza B, influenza C virus infections, including avian influenza virus subtypes (such as H5N1 avian influenza virus).
    Type: Application
    Filed: April 4, 2013
    Publication date: December 19, 2013
    Applicant: OBIO PHARMACEUTICAL (H.K.) LIMITED
    Inventors: HAO YI LIANG, FRANCIS CHI, QINGFU XU, BILL PIU CHAN
  • Materials and methods for treating viral infections
    Patent number: 8415398
    Abstract: The subject invention provides materials and methods for treating various health conditions, including the prevention and/or treatment of a viral infection. In a preferred embodiment, a cysteamine compound is administered to a subject to treat an influenza virus infection. More preferably, a cysteamine compound is administered to a subject to treat influenza A, influenza B, influenza C virus infections, including avian influenza virus subtypes (such as H5N1 avian influenza virus).
    Type: Grant
    Filed: November 28, 2006
    Date of Patent: April 9, 2013
    Assignee: Obio Pharmaceutical (H.K.) Limited
    Inventors: Hao Yi Liang, Francis Chi, Qingfu Xu, Bill Piu Chan
  • Materials and Methods for Treating Influenza Infections
    Publication number: 20100151042
    Abstract: The subject invention provides materials and methods for treating various health conditions, including the prevention and/or treatment of an influenza viral infection. In a preferred embodiment, a cysteamine compound and viral therapeutic are concurrently administered to a subject to treat an influenza virus infection. More preferably, a cysteamine compound is concurrently administered with a viral therapeutic to a subject to treat influenza A, influenza B, influenza C virus infections, including avian influenza virus subtypes (such as H5N1 avian influenza virus).
    Type: Application
    Filed: May 27, 2008
    Publication date: June 17, 2010
    Inventors: Hao Yi Liang, Francis Chi, Qingfu Xu, Bill Piu Chan